German pharmaceutical company Stada Arzneimittel is intended to be fully acquired by either Cinven Partners and Advent International Corporation, which have both submitted bids.

“US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.”

Both companies that bid for the acquisition are based in the US.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.

The acquisition will help NexImmune expand its portfolio in immuno-oncology and other immune-mediated disease areas.

The consortium, led by Celgene and CEOs of Medtronic, also includes other private investors.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.